Private equity firm TPG Capital is homing in on a deal to acquire medicine and healthcare products company iNova Pharmaceuticals.
Private equity firm TPG Capital is homing in on a deal to acquire medicine and healthcare products company iNova Pharmaceuticals.PEP and Carlyle bought iNova in 2017 from US giant Valeant Pharmaceuticals.
Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
Sources said TPG had emerged from the auction as the most likely buyer after owners Pacific Equity Partners and The Carlyle Group took binding bids on Friday.
The business is expected to be worth more than $2 billion.TPG Capital was one of three known bidders – the others were its global PE rivals Blackstone and Bain Capital.
Sources said the talks to sign a deal were well advanced on Tuesday morning.
Source: Headtopics
Can’t stop reading? Read more
Fund Friday: Top fundraising news in private equity
Fund Friday: Top fundraising news in private equity KKR has closed its North America Fund XIV at...
OVS secures $330m financing as TIP-backed retailer strengthens balance sheet
OVS secures $330m financing as TIP-backed retailer strengthens balance sheet OVS has secured a...
Ares and Antares arrange $1bn private credit deal for Pritzker-backed PLZ
Ares and Antares arrange $1bn private credit deal for Pritzker-backed PLZ Ares and Antares have...